Product Information
CAPECITABINE 150 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.3615 per EA under NDC 69097094903. Its NADAC has been published 105 times since Aug 21, 2024.
FDA first approved this application on Jul 2, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Cipla USA Inc.NDC
69097094903
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
6/17/2026
Active Ingredients
CAPECITABINEApproval Type
Generic (ANDA)
FDA Application
ANDA209365FDA Approved
7/2/2018
TE Code
AB
On Market Since
7/1/2023
Pharmacological Classes
Price Statistics
The NADAC for CAPECITABINE 150 MG TABLET has been published 105 times since Aug 21, 2024, and over the history we have for it it has declined 17.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3615 per EA |
|---|---|
| All-time high | $0.4399 (Sep 11, 2024) |
| All-time low | $0.2292 (Mar 19, 2025) |
| 52-week high | $0.4038 |
| 52-week low | $0.3615 |
| Median price | $0.3675 |
| Average price | $0.3510 |
| Largest weekly change | -37.1% (Nov 20, 2024) |
| Weeks tracked | 105 |
| Tracking since | Aug 21, 2024 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CAPECITABINE 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CAPECITABINE 150 MG TABLET, manufactured by Cipla USA Inc., is $0.3615 per EA (NDC 69097094903), effective Aug 19, 2026.
How has the price of CAPECITABINE 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for CAPECITABINE 150 MG TABLET has declined 17.8%. It has been tracked across 105 weekly CMS publications since Aug 21, 2024.
What are the highest and lowest recorded NADAC prices for CAPECITABINE 150 MG TABLET?
Since Aug 21, 2024, the NADAC for CAPECITABINE 150 MG TABLET has ranged from a low of $0.2292 (Mar 19, 2025) to a high of $0.4399 (Sep 11, 2024), with a median of $0.3675 per EA.
Are there cheaper alternatives to CAPECITABINE 150 MG TABLET?
9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CAPECITABINE 150 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CAPECITABINE 150 MG TABLET?
CAPECITABINE 150 MG TABLET (NDC 69097094903) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.